Press Releases
CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.
May 14, 2021
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
May 12, 2021
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
May 11, 2021
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
December 14, 2020
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial
November 18, 2020
CIRM-Funded Clinical Trial for Sickle Cell Gives Hope to People Battling the Disease
CIRM-Funded Clinical Trial for Sickle Cell Gives Hope to People Battling the Disease
September 8, 2020
California’s Stem Cell Agency and the Chan Zuckerberg Initiative Partner to Create COVID-19 Database
California’s Stem Cell Agency and the Chan Zuckerberg Initiative Partner to Create COVID-19 Database
March 27, 2020
Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
December 16, 2019
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
October 31, 2019
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
October 9, 2019
New Report Says Stem Cell Agency Produces Measurable Economic Benefits for California
New Report Says Stem Cell Agency Produces Measurable Economic Benefits for California
May 1, 2019
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
March 21, 2019
Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
February 21, 2019
Stem Cell Agency Invests in Chemotherapy-Free Approach to Rare But Deadly Childhood Disease
Stem Cell Agency Invests in Chemotherapy-Free Approach to Rare But Deadly Childhood Disease
October 18, 2018
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
July 19, 2018
Late-Stage Preclinical Research Targeting Prostate Cancer Gets Almost $4 Million Support from California’s Stem Cell Agency
Late-Stage Preclinical Research Targeting Prostate Cancer Gets Almost $4 Million Support from California’s Stem Cell Agency
June 28, 2018
California’s Stem Cell Agency Invests in Research Developing New Treatments for Parkinson’s and Brain Tumors
California’s Stem Cell Agency Invests in Research Developing New Treatments for Parkinson’s and Brain Tumors